Brainsway Ltd Net Assets
Brainsway Ltd net assets. Based on the latest financial reports, Brainsway Ltd (BWAY) has net assets worth ILA79.19 Million ILA (≈ $212.30K USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA121.97 Million ≈ $327.01K USD) and total liabilities (ILA42.79 Million ≈ $114.71K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is Brainsway Ltd growing its equity to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA79.19 Million |
| % of Total Assets | 64.92% |
| Annual Growth Rate | 18.1% |
| 5-Year Change | 36.53% |
| 10-Year Change | 660.83% |
| Growth Volatility | 84.26 |
Net Assets of Brainsway Ltd (2012–2025)
Net assets of Brainsway Ltd from 2012 to 2025. This chart illustrates how Brainsway Ltd's net assets have evolved over time, based on quarterly financial data. See BWAY equity financing ratio to measure how much of total assets are equity-financed.
Annual Net Assets for Brainsway Ltd (2012–2025)
The table below shows the annual net assets of Brainsway Ltd from 2012 to 2025. For live market cap and overall valuation, see BWAY market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ILA78.27 Million ≈ $209.83K |
+25.60% |
| 2024-12-31 | ILA62.31 Million ≈ $167.06K |
+49.86% |
| 2023-12-31 | ILA41.58 Million ≈ $111.48K |
-8.41% |
| 2022-12-31 | ILA45.40 Million ≈ $121.71K |
-20.81% |
| 2021-12-31 | ILA57.32 Million ≈ $153.68K |
+191.96% |
| 2020-12-31 | ILA19.63 Million ≈ $52.64K |
-18.93% |
| 2019-12-31 | ILA24.22 Million ≈ $64.93K |
+248.39% |
| 2018-12-31 | ILA6.95 Million ≈ $18.64K |
-45.35% |
| 2017-12-31 | ILA12.72 Million ≈ $34.10K |
+23.66% |
| 2016-12-31 | ILA10.29 Million ≈ $27.58K |
-20.22% |
| 2015-12-31 | ILA12.89 Million ≈ $34.57K |
-17.22% |
| 2014-12-31 | ILA15.58 Million ≈ $41.76K |
+6.32% |
| 2013-12-31 | ILA14.65 Million ≈ $39.28K |
+62.65% |
| 2012-12-31 | ILA9.01 Million ≈ $24.15K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Brainsway Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6222089200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Brainsway Ltd Net Assets Breakdown (December 2025)
Brainsway Ltd net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ILA430.09K | 0.59% |
| Other Comprehensive Income | ILA1.32 Million | 1.80% |
| Other Components | ILA162.25 Million | 221.55% |
| Total Equity | ILA73.24 Million | 100.00% |
Brainsway Ltd Competitors by Market Cap
The table below lists competitors of Brainsway Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hung Ching Development & Construction Co Ltd
TW:2527
|
$394.61 Million |
|
Sports Gear Co. Ltd
TW:6768
|
$394.64 Million |
|
Vishnu Chemicals Limited
NSE:VISHNU
|
$394.68 Million |
|
Ningxia Xiaoming Agriculture & Animal Husbandry Co.Ltd
SHE:300967
|
$394.70 Million |
|
SAMPYO Cement Co. Ltd
KQ:038500
|
$394.32 Million |
|
North American Financial 15
TO:FFN
|
$394.29 Million |
|
Issta Lines Ltd
TA:ISTA
|
$394.29 Million |
|
Eurocharm Holdings Co Ltd
TW:5288
|
$394.16 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Brainsway Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 62,313,000 to 73,236,200, a change of 10,923,200 (17.5%).
- Net income of 8,262,499 contributed positively to equity growth.
- Other comprehensive income increased equity by 3,506,273.
- Other factors decreased equity by 845,572.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA8.26 Million | +11.28% |
| Other Comprehensive Income | ILA3.51 Million | +4.79% |
| Other Changes | ILA-845.57K | -1.15% |
| Total Change | ILA- | 17.53% |
Book Value vs Market Value Analysis
This analysis compares Brainsway Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2116.79x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 9090.31x to 2116.79x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | ILA0.40 | ILA3656.00 | x |
| 2013-12-31 | ILA0.61 | ILA3656.00 | x |
| 2014-12-31 | ILA1.09 | ILA3656.00 | x |
| 2015-12-31 | ILA0.89 | ILA3656.00 | x |
| 2016-12-31 | ILA0.71 | ILA3656.00 | x |
| 2017-12-31 | ILA0.86 | ILA3656.00 | x |
| 2018-12-31 | ILA0.42 | ILA3656.00 | x |
| 2019-12-31 | ILA1.18 | ILA3656.00 | x |
| 2020-12-31 | ILA0.88 | ILA3656.00 | x |
| 2021-12-31 | ILA1.84 | ILA3656.00 | x |
| 2022-12-31 | ILA1.48 | ILA3656.00 | x |
| 2023-12-31 | ILA1.25 | ILA3656.00 | x |
| 2024-12-31 | ILA1.79 | ILA3656.00 | x |
| 2025-12-31 | ILA1.73 | ILA3656.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Brainsway Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.28%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.62%
- • Asset Turnover: 0.50x
- • Equity Multiplier: 1.54x
- Recent ROE (11.28%) is above the historical average (-40.17%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -120.88% | -1624.27% | 0.03x | 2.18x | ILA-6.41 Million |
| 2013 | -91.00% | -598.99% | 0.07x | 2.28x | ILA-7.90 Million |
| 2014 | -42.02% | -193.64% | 0.13x | 1.65x | ILA-8.10 Million |
| 2015 | -31.69% | -60.10% | 0.31x | 1.72x | ILA-5.38 Million |
| 2016 | -23.30% | -20.80% | 0.58x | 1.94x | ILA-3.43 Million |
| 2017 | -55.45% | -63.29% | 0.41x | 2.12x | ILA-8.33 Million |
| 2018 | -93.20% | -39.51% | 0.69x | 3.39x | ILA-7.17 Million |
| 2019 | -42.64% | -44.71% | 0.60x | 1.60x | ILA-12.75 Million |
| 2020 | -27.43% | -24.41% | 0.65x | 1.73x | ILA-7.35 Million |
| 2021 | -11.27% | -21.79% | 0.39x | 1.32x | ILA-12.19 Million |
| 2022 | -29.41% | -49.12% | 0.42x | 1.42x | ILA-17.89 Million |
| 2023 | -10.09% | -13.20% | 0.50x | 1.51x | ILA-8.36 Million |
| 2024 | 4.69% | 7.12% | 0.43x | 1.51x | ILA-3.31 Million |
| 2025 | 11.28% | 14.62% | 0.50x | 1.54x | ILA938.88K |
Industry Comparison
This section compares Brainsway Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $21,251,000
- Average return on equity (ROE) among peers: -47.45%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Brainsway Ltd (BWAY) | ILA79.19 Million | -120.88% | 0.54x | $394.54 Million |
| Allmed Solutions Ltd (ALMD) | $53.96 Million | -20.74% | 0.07x | $7.88 Million |
| Erika Carmel Ltd (BCUR) | $15.04 Million | -62.98% | 1.31x | $4.69 Million |
| Bio-View Ltd (BIOV) | $27.61 Million | 16.07% | 0.40x | $20.36 Million |
| Erech Finance Cahalacha Ltd (EFNC) | $28.37 Million | -88.27% | 1.44x | $816.18K |
| Epitomee Medical Ltd (EPIT) | $33.95 Million | -15.68% | 0.18x | $28.14 Million |
| Erika Carmel-Tech Ltd (ERKA) | $8.97 Million | 138.94% | 4.32x | $4.46 Million |
| Human Xtensions Ltd (HUMX) | $15.51 Million | -184.33% | 0.31x | $2.12 Million |
| Pulsenmore Ltd (PULS) | $3.75 Million | -126.31% | 0.60x | $22.89 Million |
| Sofwave Medical Ltd (SOFW) | $4.12 Million | -83.72% | 0.51x | $357.45 Million |
About Brainsway Ltd
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, … Read more